company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4238000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4238000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,30000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,324000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-92000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3976000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3976000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,2500000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2500000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2500000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2012.0,Q4,2011-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1476000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5611000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5611000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,204000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,216000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5157000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5157000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,5500000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,30000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5530000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5530000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 16:05:39+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,373000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6869000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6869000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,35000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,242000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,436000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6156000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6156000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,23057000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23059000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23059000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16903000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33947000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33947000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,144000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3873000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-360000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30290000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30290000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,72434000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,113496000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,185930000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,185930000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2013.0,Q4,2013-01-01,2013-12-31,2016-03-15 16:13:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,155583000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13694000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13694000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2846000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,236000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10569000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10569000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-125000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-400000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-525000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-525000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,13000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,13000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:02:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11081000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16431000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16431000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3888000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,619000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11882000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11882000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-324000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-324000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-324000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-427000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,47000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-380000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-380000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12586000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19724000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19724000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,106000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2965000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,424000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16229000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16229000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2286000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2286000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2286000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,427000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,112912000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,113339000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,113339000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,94824000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25928000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25928000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,132000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4591000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8436000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12767000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12767000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-99000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-63797000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-63896000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-63896000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,149000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,149000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,149000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-76522000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26067000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26067000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,136000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-231000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3749000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2212000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20225000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20225000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-178000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-184902000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15000000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-170080000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-170080000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,91160000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,91160000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,91160000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:08:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-99156000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32695000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32695000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,156000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1047000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4482000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1113000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28099000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28099000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-596000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24615000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26069000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,858000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,858000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-27222000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30373000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30373000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,165000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,527000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3482000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,869000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-25330000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25330000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-137000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-52957000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,97735000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-85000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,44556000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,44556000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,39000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,39000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19268000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29046000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29046000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,177000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,435000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6029000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2030000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20375000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20375000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-505000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42718000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,77063000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,33843000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,33843000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1484000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1484000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1484000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-93000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14859000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27059000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27059000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,179000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,314000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5158000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1757000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23165000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23165000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-59003000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,65793000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6751000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6751000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,196000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,196000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,196000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,48000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:07:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16170000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30158000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30158000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,179000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,281000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6405000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2399000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20894000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20894000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28030000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44253000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16217000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16217000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,436000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-196000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,240000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,240000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-34000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4471000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25425000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25425000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,179000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,244000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5594000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-926000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20334000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20334000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35648000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,30673000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4975000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4975000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,31479000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31479000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31479000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,21000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6191000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26935000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26935000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,180000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,360000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5126000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1271000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19998000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19998000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12019000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18646000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6602000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6602000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19288000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,39000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19249000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19249000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-98000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5755000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29917000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29917000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,183000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,267000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5909000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1150000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24708000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24708000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25075000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25624000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,549000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,549000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,57000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,57000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,57000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,16000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:06:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24086000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29387000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29387000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,180000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,325000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5129000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2032000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21721000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21721000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36489000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35355000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1134000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1134000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,52569000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52569000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52569000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,95000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,29809000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30640000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30640000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,176000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,311000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4868000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3535000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21750000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21750000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12453000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,33054000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20594000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20594000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,160000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,160000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,160000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,70000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-926000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39040000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39040000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,174000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,284000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4499000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28545000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5538000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5538000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-55000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24357000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21511000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2901000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2901000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22957000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22957000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22957000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,200000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-181000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14537000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38459000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38459000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,169000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-160000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4164000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-270000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34556000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34652000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-382000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-24736000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27602000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2484000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2484000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,429000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,429000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,429000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,43000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:10:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31696000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33655000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33655000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,184000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,430000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4440000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9123000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-37724000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-37628000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-397000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50207000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23000000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27604000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27604000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,147132000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,147132000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,147132000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-87000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,81813000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48083000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48083000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,188000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,10000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4774000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4446000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38665000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38665000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-491000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-22719000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43776000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,20566000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,20566000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,772000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,772000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,772000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,35000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17292000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-58210000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-58210000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,194000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1169000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3897000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4778000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-48172000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-48172000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1093000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-145149000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43132000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-103110000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-103110000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,166885000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,891000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,167776000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,167776000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,9000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16425000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-66161000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-66161000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,245000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1182000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4170000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6059000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-66623000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-66623000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-49000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-27993000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,60033000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31991000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31991000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,152000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,152000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,152000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-37000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q1,2019-01-01,2019-03-31,2019-05-09 16:10:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34517000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36506000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-36506000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-107000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43661000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,83943000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40175000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40175000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,88822000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,88822000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,92421000.0
Karyopharm Therapeutics Inc,KPTI,549300J1VANRCNTYST87,0001503802,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,184912000.0
